J&J-MERCK CAN PAVE WAY FOR PEPCID OTC SWITCH WITH PROMO PUSH FOR MYLANTA: ICI TRADES LOW PRIORITY PROJECT FOR ELAVIL AND Rx FOCUS

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".